These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3004507)

  • 21. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
    Kurtzberg J; Hershfield MS
    Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solar and UVC-induced mutation in human cells and inhibition by deoxynucleosides.
    Musk P; Campbell R; Staples J; Moss DJ; Parsons PG
    Mutat Res; 1989 Sep; 227(1):25-30. PubMed ID: 2770776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interference of deoxyadenosine with transmembrane signaling events in human T lymphocytes.
    Scharenberg JG; Rijkers GT; Akkerman JW; Staal GE; Zegers BJ
    Int J Immunopharmacol; 1990; 12(1):113-20. PubMed ID: 2303314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance of pokeweed mitogen-stimulated B cells to inhibition by deoxyadenosine.
    Hayward AR
    Clin Exp Immunol; 1980 Jul; 41(1):141-9. PubMed ID: 6969149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of 2-chloro-2'-deoxyadenosine on metabolism of deoxyadenosine in human primary CNS lymphoma.
    Fabianowska-Majewska K; Tybor K; Duley J; Simmonds A
    Biochem Pharmacol; 1995 Oct; 50(9):1379-83. PubMed ID: 7503787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative sensitivity of human T cell subsets to deoxyadenosine toxicity.
    Callard RE; Ewing TM; Fox RM
    Clin Exp Immunol; 1984 Oct; 58(1):136-44. PubMed ID: 6236916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the mechanism of cytotoxicity of 3'-deoxyadenosine N1-oxide in different strains of Ehrlich ascites tumor cells.
    Svendsen KR; Overgaard-Hansen K; Frederiksen S; Loft H; Engelholm SA
    Cancer Chemother Pharmacol; 1987; 19(2):118-22. PubMed ID: 3494546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5'-Deoxyadenosine metabolism in various mammalian cell lines.
    Plagemann PG; Wohlhueter RM
    Biochem Pharmacol; 1983 Apr; 32(8):1433-40. PubMed ID: 6602613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purine metabolizing enzymes as predictors of lymphoblast sensitivity to deoxyadenosine.
    Mitchell BS; Edwards NL
    J Lab Clin Med; 1984 Sep; 104(3):414-24. PubMed ID: 6147383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine.
    Fox RM; Kefford RF; Tripp EH; Taylor IW
    Cancer Res; 1981 Dec; 41(12 Pt 1):5141-50. PubMed ID: 6272990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consequences of adenosine deaminase deficiency on thymocyte metabolism.
    Thuillier L; Garreau F; Cartier PH
    Eur J Immunol; 1981 Oct; 11(10):788-94. PubMed ID: 6975717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of G2-treatments with 2'-deoxyadenosine on the frequency of chromatid aberrations in human lymphocytes depends on the type of culture.
    Kihlman BA; Andersson HC
    Chromosoma; 1984; 90(4):239-42. PubMed ID: 6334594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.
    Seto S; Carrera CJ; Kubota M; Wasson DB; Carson DA
    J Clin Invest; 1985 Feb; 75(2):377-83. PubMed ID: 2579098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical basis for differential deoxyadenosine toxicity to T and B lymphoblasts: role for 5'-nucleotidase.
    Wortmann RL; Mitchell BS; Edwards NL; Fox IH
    Proc Natl Acad Sci U S A; 1979 May; 76(5):2434-7. PubMed ID: 221924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Terminal incorporation of 2'-deoxyadenosine into polyadenylate segments of polyadenylated RNA in G1-phase-arrested human T-lymphoblasts.
    Kefford RF; Fox RM; McCairns E; Fahey D; Muscat GE; Rowe PB
    Cancer Res; 1983 May; 43(5):2252-7. PubMed ID: 6187447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
    Kable EP; Favier D; Parsons PG
    Cancer Res; 1989 May; 49(9):2327-31. PubMed ID: 2706620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA damage and selective toxicity of dopa and ascorbate:copper in human melanoma cells.
    Parsons PG; Morrison LE
    Cancer Res; 1982 Sep; 42(9):3783-8. PubMed ID: 6809313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ecto-5'-nucleotidase can provide the total purine requirements of mitogen-stimulated human T cells and rapidly dividing human B lymphoblastoid cells.
    Thompson LF
    J Immunol; 1985 Jun; 134(6):3794-7. PubMed ID: 2985697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased methionine synthesis in purine nucleoside-treated T and B lymphoblasts and reversal by homocysteine.
    Boss GR; Pilz RB
    J Clin Invest; 1984 Oct; 74(4):1262-8. PubMed ID: 6332827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different sites of adenosine formation in the heart.
    Schütz W; Schrader J; Gerlach E
    Am J Physiol; 1981 Jun; 240(6):H963-70. PubMed ID: 6264801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.